Hanley Jr. Michael Conick
- SEC CIK
- 0001791413
No open-market purchases or sales filed in the past year.
Current role at each company
- ANRO Alto Neuroscience, Inc.CHIEF OPERATING OFFICERas of Feb 13, 2026
- SYRE Spyre Therapeutics, Inc.Chief Business Officeras of Feb 24, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Hanley Jr. Michael Conick as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SYRE Spyre Therapeutics, Inc.
Chief Business Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 10, 2022 (view filing) | Jun 8 | 2 days | Hanley Jr. Michael ConickChief Commercial Officer | PPurchase | +28.2K | $0.71 | +$20.0K | +352.5%36.2K after |